Longboard Pharmaceuticals Future Growth
Future criteria checks 2/6
Longboard Pharmaceuticals's earnings are forecast to decline at 0.09% per annum while its annual revenue is expected to grow at 74.4% per year. EPS is expected to grow by 9% per annum. Return on equity is forecast to be -76.7% in 3 years.
Key information
-0.09%
Earnings growth rate
9.0%
EPS growth rate
| Pharmaceuticals earnings growth | 22.9% |
| Revenue growth rate | 74.4% |
| Future return on equity | -76.7% |
| Analyst coverage | Good |
| Last updated | 16 Apr 2024 |
Recent future growth updates
Recent updates
Longboard Pharmaceuticals: After Stellar Gains, A Period Of Relative Calm Seems Likely
Mar 16Will Longboard Pharmaceuticals (NASDAQ:LBPH) Spend Its Cash Wisely?
Oct 03
We're Keeping An Eye On Longboard Pharmaceuticals' (NASDAQ:LBPH) Cash Burn Rate
Dec 25Companies Like Longboard Pharmaceuticals (NASDAQ:LBPH) Are In A Position To Invest In Growth
Sep 10We're Hopeful That Longboard Pharmaceuticals (NASDAQ:LBPH) Will Use Its Cash Wisely
May 28Longboard Pharmaceuticals (NASDAQ:LBPH) Is In A Good Position To Deliver On Growth Plans
Feb 11Here's Why We're Not At All Concerned With Longboard Pharmaceuticals' (NASDAQ:LBPH) Cash Burn Situation
Oct 27Longboard Pharmaceuticals (NASDAQ:LBPH) Is In A Strong Position To Grow Its Business
Jun 12Longboard Pharmaceuticals EPS beats by $0.29
May 10Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 6 | -120 | -102 | -86 | 5 |
| 12/31/2025 | N/A | -104 | -96 | -73 | 6 |
| 12/31/2024 | 3 | -74 | -62 | -54 | 6 |
| 12/31/2023 | N/A | -54 | -51 | -51 | N/A |
| 9/30/2023 | N/A | -51 | -50 | -50 | N/A |
| 6/30/2023 | N/A | -49 | -46 | -46 | N/A |
| 3/31/2023 | N/A | -46 | -41 | -41 | N/A |
| 12/31/2022 | N/A | -44 | -38 | -38 | N/A |
| 9/30/2022 | N/A | -41 | -34 | -34 | N/A |
| 6/30/2022 | N/A | -36 | -30 | -30 | N/A |
| 3/31/2022 | N/A | -32 | -27 | -27 | N/A |
| 12/31/2021 | N/A | -28 | -25 | -25 | N/A |
| 9/30/2021 | N/A | -29 | -21 | -20 | N/A |
| 6/30/2021 | N/A | -25 | -15 | -15 | N/A |
| 3/31/2021 | N/A | -20 | -11 | -11 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: LBPH is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: LBPH is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: LBPH is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: LBPH's revenue (74.4% per year) is forecast to grow faster than the US market (8.1% per year).
High Growth Revenue: LBPH's revenue (74.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: LBPH is forecast to be unprofitable in 3 years.